Acquired reactive perforating collagenosis secondary to Cabozantinib: A case report and literature review
Zahra Rehan, Andrea Haner, Amina Taleb, Nzechukwu Ikeri, Jori Hardin · 2024
Read Acquired reactive perforating collagenosis secondary to Cabozantinib: A case report and literature review by Zahra Rehan, Andrea Haner, Amina Taleb, Nzechukwu Ikeri, Jori Hardin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11650492.txt.
Description
Zahra Rehan and co-authors report in 2024 a skin illness that appeared during treatment with a cancer drug. The illness, acquired reactive perforating collagenosis, pushes collagen out through the skin and forms rough spots. It is most often linked with diabetes, kidney failure, or certain drugs.
Here the authors tie a new case to cabozantinib, a drug used against several cancers, and they review past reports of the condition. Naming the link matters, since doctors who spot the rash can weigh whether the drug is the cause and adjust care. The report adds one more drug to the list of known triggers for this rare skin response.
Catalog record
| CREATOR | Zahra Rehan, Andrea Haner, Amina Taleb, Nzechukwu Ikeri, Jori Hardin |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |